Table 1 Baseline demographic and clinical characteristics of study participants.

From: Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study

 

Variable

Mean ± SD or N (%)

Demographics

Age (Mean ± SD)

53.5 ± 15.8

Female, N (%)

13(44.8%)

METAVIR 3/4, N (%)

8(27.6%)

Genotype N (%)

1B

19 (65.5%)

1A

2 (6.9%)

2

1 (3.5%)

3

7 (24.1%)

Laboratory at baseline

ALT U/L (Mean ± SD)

56.1 ± 33.4

Total Bilirubin mg/dL (Mean ± SD)

0.65 ± 0.5

Albumin g/dL (Mean ± SD)

4.4 ± 0.3

Hb g/dL (Mean ± SD)

14.2 + 1.4

PLT Count 106/mm6 (Mean ± SD)

53.5 ± 15.7

HCV RNA IU/mL (Mean ± SD)

2.6 × 106 ± 3.2 × 105

  1. SD, standard deviation; ALT, alanine aminotransferase; Hb, hemoglobin; PLT, platelets; HCV, hepatitis C virus; RNA, ribonucleic acid.